Christopher S Lathan

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Perspectives of african americans on lung cancer: a qualitative analysis
    Christopher S Lathan
    McGraw Patterson Center for Population Sciences, Dana Farber Cancer Center, Boston, Massachusetts, USA
    Oncologist 20:393-9. 2015
  2. pmc Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey
    Christopher S Lathan
    Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 116:1981-6. 2010
  3. pmc Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer
    Christopher S Lathan
    Department of Medical Oncology, Division of Population Sciences, Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 26:4347-52. 2008
  4. ncbi request reprint The effect of race on invasive staging and surgery in non-small-cell lung cancer
    Christopher S Lathan
    Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 24:413-8. 2006
  5. doi request reprint Racial differences in prostate cancer screening by family history
    Bettina F Drake
    Department of Society, Human Development and Health, Center for Community Based Research, Harvard School of Public Health, Boston, MA, USA
    Ann Epidemiol 18:579-83. 2008
  6. pmc Attitudes of patients with cancer about personalized medicine and somatic genetic testing
    Stacy W Gray
    Center for Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, LW 633, Boston, MA 02215, USA
    J Oncol Pract 8:329-35, 2 p following 335. 2012
  7. pmc Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life
    Tracy A Balboni
    Harvard Radiation Oncology Program, Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 25:555-60. 2007
  8. pmc Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research
    Julie A Lynch
    Veterans Health Administration, University of Massachusetts Boston and Dana Farber Cancer Institute, Boston, MA, USA
    Genet Med 15:630-8. 2013
  9. pmc Integrating multiple social statuses in health disparities research: the case of lung cancer
    David R Williams
    Department of Society, Human Development and Health, Harvard University, School of Public Health, 677 Huntington Avenue, 6th Floor, Boston, MA, 02215, USA
    Health Serv Res 47:1255-77. 2012
  10. doi request reprint Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium
    Dolly A John
    Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts
    Cancer 120:3178-91. 2014

Detail Information

Publications10

  1. doi request reprint Perspectives of african americans on lung cancer: a qualitative analysis
    Christopher S Lathan
    McGraw Patterson Center for Population Sciences, Dana Farber Cancer Center, Boston, Massachusetts, USA
    Oncologist 20:393-9. 2015
    ..The objective of this study was to explore African Americans' knowledge of lung cancer, perceived risk, interest in smoking cessation, attitudes toward lung cancer treatment, and lung cancer diagnosis and treatment experiences...
  2. pmc Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey
    Christopher S Lathan
    Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 116:1981-6. 2010
    ..Racial disparities in lung cancer have been described well in the literature; however, little is known about perceptions of lung cancer in the general population and whether these perceptions differ by race...
  3. pmc Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer
    Christopher S Lathan
    Department of Medical Oncology, Division of Population Sciences, Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 26:4347-52. 2008
    ..Our study examines the relationship between the percentage of black patients treated at a hospital to determine whether it affects the likelihood of obtaining cancer-directed surgery for patients with non-small-cell lung cancer (NSCLC)...
  4. ncbi request reprint The effect of race on invasive staging and surgery in non-small-cell lung cancer
    Christopher S Lathan
    Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 24:413-8. 2006
    ..To isolate the effect of decision making from access to care, we used receipt of surgical staging as a proxy for access and willingness to undergo invasive procedures, and examined treatments and outcomes by race...
  5. doi request reprint Racial differences in prostate cancer screening by family history
    Bettina F Drake
    Department of Society, Human Development and Health, Center for Community Based Research, Harvard School of Public Health, Boston, MA, USA
    Ann Epidemiol 18:579-83. 2008
    ..Therefore we examined racial variation in the association of family history of CaP and self-reported prostate-specific antigen (PSA) testing in the nationally-representative National Health Interview Survey (NHIS)...
  6. pmc Attitudes of patients with cancer about personalized medicine and somatic genetic testing
    Stacy W Gray
    Center for Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, LW 633, Boston, MA 02215, USA
    J Oncol Pract 8:329-35, 2 p following 335. 2012
    ..Dramatic advances in genomic technology stand to revolutionize cancer care; however, little is known about patients' understanding and acceptance of personalized medicine and widespread genetic testing (GT)...
  7. pmc Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life
    Tracy A Balboni
    Harvard Radiation Oncology Program, Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 25:555-60. 2007
    ..This study examined religiousness and spiritual support in advanced cancer patients of diverse racial/ethnic backgrounds and associations with quality of life (QOL), treatment preferences, and advance care planning...
  8. pmc Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research
    Julie A Lynch
    Veterans Health Administration, University of Massachusetts Boston and Dana Farber Cancer Institute, Boston, MA, USA
    Genet Med 15:630-8. 2013
    ..Our goal was to inform the development of a model to predict phase 3 translation of guideline-directed molecular diagnostic tests...
  9. pmc Integrating multiple social statuses in health disparities research: the case of lung cancer
    David R Williams
    Department of Society, Human Development and Health, Harvard University, School of Public Health, 677 Huntington Avenue, 6th Floor, Boston, MA, 02215, USA
    Health Serv Res 47:1255-77. 2012
    ....
  10. doi request reprint Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium
    Dolly A John
    Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts
    Cancer 120:3178-91. 2014
    ....